Latest ALS (Lou Gehrig's Disease) news
Antisense Oligonucleotide Tofersen Reduces SOD1 in SOD1 ALS
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Approves New ALS Drug Despite Uncertain Data
posted September 30th
by modernClinician Editorial Team
by modernClinician Editorial Team
Hospital-Treated Infections Earlier in Life Tied to Alzheimer, Parkinson Disease Risk
posted September 28th
by modernClinician Editorial Team
by modernClinician Editorial Team
Recommendations Provided for Managing Shift Work Disorder 
On-Duty Cardiac Deaths Elevated Among Firefighters 
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate 
Past Blast Exposure Tied to Long-Term Chronic Medical Diagnoses in Veterans 
New ALS Drug Approved in Canada While Still Under FDA Review 
FDA Advisory Panel Narrowly Votes Against New ALS Drug Monthly Specialist Briefings
Stay Connected
